With demonstrated clinical development and commercialization expertise, VIVUS is dedicated to addressing the therapeutic needs of patients with serious medical conditions and life-limiting diseases. We are a focused organization with the expertise and insights to advance innovative new therapies.
Recent Press Releases
View All Press Releases
View All Events & Presentations
Financials + Filings
VIVUS Stock and Financial Information
SEC Filings Link
Quarterly Results Link
View Financial Information
Vivus Stock Chart and Information
The stock information provided is for informational purposes only and is not intended for trading purposes. The stock information and stock charts are provided by NASDAQ, a third party service provider, and VIVUS, Inc. does not maintain or provide information directly to this service. Stock information is delayed approximately 20 minutes.